CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 195 filers reported holding CHEMOCENTRYX INC in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $12,860,000 | -10.7% | 248,943 | -57.2% | 0.00% | 0.0% |
| Q2 2022 | $14,398,000 | -11.1% | 581,050 | -10.0% | 0.00% | 0.0% |
| Q1 2022 | $16,191,000 | -8.9% | 645,833 | +32.4% | 0.00% | 0.0% |
| Q4 2021 | $17,765,000 | -94.3% | 487,909 | -92.0% | 0.00% | -94.5% |
| Q1 2021 | $313,141,000 | -17.8% | 6,111,277 | -0.6% | 0.06% | -21.4% |
| Q4 2020 | $380,726,000 | +3.6% | 6,148,679 | -8.3% | 0.07% | -7.9% |
| Q3 2020 | $367,343,000 | +33.1% | 6,703,334 | +39.7% | 0.08% | +24.6% |
| Q2 2020 | $276,030,000 | +66573.9% | 4,797,171 | +14519.7% | 0.06% | – |
| Q3 2018 | $414,000 | -4.2% | 32,813 | 0.0% | 0.00% | – |
| Q2 2018 | $432,000 | -83.6% | 32,813 | -82.4% | 0.00% | -100.0% |
| Q2 2013 | $2,641,000 | – | 186,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |